ADVFN ADVFN

Hot Features

Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Altamira Therapeutics Ltd (ID)

Altamira Therapeutics Ltd (ID) (CYTOF)

0.0711
0.00
(0.00%)
終了 6月12日 5:00AM

Altamira Therapeutics Ltd (ID) (CYTOF) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

主要統計と詳細

通貨
0.0711
( - )
買値
0.0711
売値
0.0711
出来高
-
0.00 日の範囲 0.00
0.0501 52 週間の範囲 0.14785
時価総額
前日終値
0.0711
始値
-
時刻
最終取引時間
財務取引量
-
VWAP
-
平均取引量 (3 か月)
US$ 4,825
発行済株式数
5,715,472
配当利回り
PER
-0.06
1 株当たり利益 (EPS)
-1.31
歳入
-
純利益
-5.65M

Altamira Therapeutics Ltd (ID) について

Altamira Therapeutics Ltd. operates as a preclinical-stage biopharmaceutical company in Switzerland, Australia, the United States, and Europe. The company develops and supplies peptide-based nanoparticle technologies for efficient RNA delivery to extrahepatic tissues through xPhore platform; and off... Altamira Therapeutics Ltd. operates as a preclinical-stage biopharmaceutical company in Switzerland, Australia, the United States, and Europe. The company develops and supplies peptide-based nanoparticle technologies for efficient RNA delivery to extrahepatic tissues through xPhore platform; and offers Bentrio, a drug-free nasal spray for protection against airborne viruses and allergens It is also developing AM-401 for the treatment of KRAS driven cancer; AM-411 for the treatment of rheumatoid arthritis; and AM-125 that is in post phase II clinical trial for the intranasal treatment of vertigo. The company was formerly known as Auris Medical Holding Ltd. and changed its name to Altamira Therapeutics Ltd. in July 2021. The company was founded in 2003 and is based in Hamilton, Bermuda. 詳細を表示

セクター
Healthcare
業界
Biotechnology & Life Sciences
ウェブサイト
本社
Hamilton, Bermuda
設立
2026
Altamira Therapeutics Ltd (ID) is listed in the Healthcare sector of the その他OTC with ticker CYTOF. The last closing price for Altamira Therapeutics (ID) was US$0.07. Over the last year, Altamira Therapeutics (ID) shares have traded in a share price range of US$ 0.0501 to US$ 0.14785.

Altamira Therapeutics (ID) currently has 5,715,472 shares in issue. The market capitalisation of Altamira Therapeutics (ID) is US$406,370.06 . Altamira Therapeutics (ID) has a price to earnings ratio (PE ratio) of -0.06.

CYTOF 最新ニュース

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.0059-7.662337662340.0770.0770.0711116900.07445679CS
4-0.0107-13.08068459660.08180.112280.050273010.08646992CS
120.011118.50.060.12480.050154610.07915805CS
26-0.0039-5.20.0750.14650.050162710.0904257CS
520.00091.282051282050.07020.147850.050178790.0857055CS
156-0.0665-48.32848837210.13760.20.0501149750.10308607CS
260-0.0665-48.32848837210.13760.20.0501149750.10308607CS

CYTOF - Frequently Asked Questions (FAQ)

What is the current Altamira Therapeutics Ltd (ID) share price?
The current share price of Altamira Therapeutics Ltd (ID) is US$ 0.0711
How many Altamira Therapeutics Ltd (ID) shares are in issue?
Altamira Therapeutics Ltd (ID) has 5,715,472 shares in issue
What is the market cap of Altamira Therapeutics Ltd (ID)?
The market capitalisation of Altamira Therapeutics Ltd (ID) is USD 406.37k
What is the 1 year trading range for Altamira Therapeutics Ltd (ID) share price?
Altamira Therapeutics Ltd (ID) has traded in the range of US$ 0.0501 to US$ 0.14785 during the past year
What is the PE ratio of Altamira Therapeutics Ltd (ID)?
The price to earnings ratio of Altamira Therapeutics Ltd (ID) is -0.06
What is the registered address of Altamira Therapeutics Ltd (ID)?
The registered address for Altamira Therapeutics Ltd (ID) is Clarendon House, Hamilton, HM 11
What is the Altamira Therapeutics Ltd (ID) website address?
The website address for Altamira Therapeutics Ltd (ID) is altamiratherapeutics.com
Which industry sector does Altamira Therapeutics Ltd (ID) operate in?
Altamira Therapeutics Ltd (ID) operates in the Biotechnology & Life Sciences sector

CYTOF 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード

CYTOF Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock